28 related articles for article (PubMed ID: 9716894)
1. The use of vasopressin in the setting of recalcitrant hypotension due to calcium channel blocker overdose.
Kanagarajan K; Marraffa JM; Bouchard NC; Krishnan P; Hoffman RS; Stork CM
Clin Toxicol (Phila); 2007; 45(1):56-9. PubMed ID: 17357383
[TBL] [Abstract][Full Text] [Related]
2. Delayed presentation of calcium channel antagonist overdose.
Punukollu G; Gowda RM; Khan IA; Dogan OM
Am J Ther; 2003; 10(2):132-4. PubMed ID: 12629592
[TBL] [Abstract][Full Text] [Related]
3. Case files of the medical toxicology fellowship training program at the New York city poison control center: hypotensive death--therapeutic complication or suicide?
Halcomb SE; Nelson LS
J Med Toxicol; 2006 Jun; 2(2):75-80. PubMed ID: 18072119
[No Abstract] [Full Text] [Related]
4. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
Levine M; Curry SC; Padilla-Jones A; Ruha AM
Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
[TBL] [Abstract][Full Text] [Related]
5. What is the best treatment for acute calcium channel blocker overdose?
Olson KR
Ann Emerg Med; 2013 Sep; 62(3):259-61. PubMed ID: 23567061
[No Abstract] [Full Text] [Related]
6. A calcium channel blocker and ibuprofen overdose.
Cimpello LB; Craig S; Lawrence E; Baker MD
Curr Opin Pediatr; 1998 Jun; 10(3):303-7. PubMed ID: 9716894
[No Abstract] [Full Text] [Related]
7. Acetaminophen and Ibuprofen overdosage.
Argentieri J; Morrone K; Pollack Y
Pediatr Rev; 2012 Apr; 33(4):188-9. PubMed ID: 22474118
[No Abstract] [Full Text] [Related]
8. [Beta-blocker and calcium antagonist poisoning. Two cardiological problems with an endocrinological solution?].
Friis-Hansen LJ; Gøtze JP; Kastrup J
Ugeskr Laeger; 2004 Sep; 166(40):3483-7. PubMed ID: 15518000
[No Abstract] [Full Text] [Related]
9. Slow channel blockers.
Covinsky JO; Hamburger SC
South Med J; 1983 Jan; 76(1):55-64. PubMed ID: 6337401
[No Abstract] [Full Text] [Related]
10. Ibuprofen and paracetamol: relative safety in non-prescription dosages.
Rainsford KD; Roberts SC; Brown S
J Pharm Pharmacol; 1997 Apr; 49(4):345-76. PubMed ID: 9232533
[No Abstract] [Full Text] [Related]
11. Adverse reactions with calcium antagonists.
Krebs R
Hypertension; 1983; 5(4 Pt 2):II125-9. PubMed ID: 6134672
[No Abstract] [Full Text] [Related]
12. Calcium-channel blocking agents: current indications and potential uses.
Pine RM
Clin Ther; 1984; 6(3):245-51. PubMed ID: 6373005
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
